Navigation Links
PneumRx, Inc. Acquires Key Assets From Broncus
Date:5/21/2012

MOUNTAIN VIEW, Calif., May 21, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has expanded its intellectual property portfolio by acquiring key patents and domain names from Broncus Technologies.

(Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO)

As a result of the acquisition, PneumRx now owns numerous domain names, including emphysema.com, as well as several foundational patents in the emphysema/interventional pulmonology space.

The newly-acquired Intellectual Property is a valuable complement to PneumRx's extensive IP portfolio. It will allow the company to further strengthen its IP position, block competing technologies, and take additional segments of the pulmonary disease market.

PneumRx currently manufactures the RePneu LVRC System, a minimally invasive device intended to improve lung function in emphysema patients by bronchoscopically implanting Nitinol coils into the lungs to compress diseased tissue (lung volume reduction), restore elastic recoil, and adjust lung compliance. This treatment offers a minimally invasive alternative to lung volume reduction surgery to a broad range of emphysema patients.

The RePneu LVRC has been approved for a 30-site IDE pivotal clinical trial in the United States. The device is offered commercially in Europe, where it received the CE Mark in 2010.

"We are most pleased with the Broncus IP acquisition, which will bolster PneumRx's position as a leader in interventional pulmonology," said Erin McGurk, PneumRx's President and CEO. "PneumRx looks forward to leveraging the newly-acquired IP in pursuit of our mission to provide solutions for the millions of people suffering from pulmonary disease."

About PneumRx, Inc.

PneumRx, Inc. is a rapidly growing medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally-invasive techniques. It is a privately held company located in Mountain View, California.


'/>"/>
SOURCE PneumRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System
2. PneumRx, Inc. Raises $33 Million in Capital
3. PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , January 24, 2017 Analysis of ... User Liquid Biopsies - our new study reveals trends, ... market heading? If you are involved in this sector you must ... the potential revenues streams to 2027, assessing data, trends, opportunities and ... ...
(Date:1/24/2017)... and GAITHERSBURG, Md. , Jan. 24, 2017 ... a leader in the engineering and industrialization of biology to ... today announced that it has entered into a definitive agreement ... ), a clinical-stage company and pioneer in the development of ... integrate and expand upon GenVec,s expertise in adenoviral vectors and ...
(Date:1/24/2017)... IRVING, Texas , Jan. 24, 2017 /PRNewswire/ ... that offers innovative and cost effective patient care ... Inc. This partnership will expand the reach of ... share and areas of expertise. ... existing product portfolio to now include Keneric Healthcare,s ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... ... clinical research networking-technology company founded by patient survivors, today announced formation of ... model, networking technologies and patient-inspired initiatives. , Like HCP founders, the ...
(Date:1/24/2017)... Arlington, Va. (PRWEB) , ... January 23, 2017 ... ... (H.R. 592) was reintroduced on Friday, January 20, with the bipartisan original co-sponsorship ... 109) was re-introduced on January 12. The National Association of Chain Drug Stores ...
(Date:1/24/2017)... Utah (PRWEB) , ... January 23, 2017 , ... The ... now) features a three-year outcome study on how outdoor behavioral healthcare (OBH) – also ... of distress and interpersonal difficulties while experiencing an increased sense of purpose both during ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... men who support them, Dr. Carol Francis, Psychologist in the South Bay ... pay, humane respectful governing for all people and by all people shines as ...
(Date:1/23/2017)... ... 2017 , ... A Northwestern Pennsylvania addiction treatment center unveiled ... Rehabilitation & Recovery Center’s new website can be found at AlpineSpringsRehab.com . ... and retooled website. The treatment center has also revamped its social media strategy, ...
Breaking Medicine News(10 mins):